Liu Chang, Ni Xiaolin, Zhao Zhen, Qi Wenting, Jiang Yan, Li Mei, Wang Ou, Xing Xiaoping, Xia Weibo
Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China; Department of Endocrinology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
Bone. 2023 Feb;167:116602. doi: 10.1016/j.bone.2022.116602. Epub 2022 Nov 5.
Autosomal dominant hypophosphatemic rickets (ADHR) is a rare disease caused by activating mutations in fibroblast growth factor 23 (FGF23) gene. With FGF23 activation, ADHR is a good model to explore the effects of FGF23 on skeletal development and mineralization. However, the bone microarchitecture of ADHR patients is poorly investigated. This study aims to illustrate the bone properties of ADHR patients and clarify the effect of FGF23 on load bearing and non-load bearing bone.
Bone microarchitectures of 11 ADHR subjects and sex- and age-matched healthy controls were analyzed by HR-pQCT. The effect of FGF23 mutations on load bearing and non-load bearing bone was explored by comparison of bone microarchitecture in distal radius and distal tibia. The BMD, bone microarchitecture and bone strength were compared between 7 ADHR patients and 7 age- and sex-matched XLH patients.
Among 11 subjects with FGF23 mutations, 10 patients presented with obvious symptoms, five of which had received 1-3 years of iron supplement, neutral phosphate, and calcitriol treatments. The symptomatic patients presented with low bone density and fractures in X rays, with decreased Z score of aBMD (L1-L4: -1.3 ± 1.4, femoral neck: -2.1 ± 1.8, total hip: -1.85 ± 1.6). Compared with controls, HR-pQCT analysis of 5 untreated ADHR patients showed increased total area (+61.6 %, p = 0.03) and cortical perimeter (+17.2 %, p = 0.03) in distal radius. No significant differences were found in other parameters in distal radius. In distal tibia, the patients presented obvious defects in cancellous bone, with decreased trabecular vBMD (-62.9 %, p = 0.003), trabecular BV/TV (-48.7 %, p = 0.003) and trabecular number (-42.2 %, p = 0.001). The trabecular separation (+113.3 %, p = 0.007) and trabecular network inhomogeneity (+226.7 %, p = 0.001) were accordingly increased. In addition to another 5 treated patients, the bone microarchitecture changes revealed similar pattern, but the increase of total area and cortical perimeter in distal radius was no longer statistically significant. The non-symptomatic ADHR patient demonstrated slightly decreased total vBMD, trabecular vBMD and trabecular BV/TV in distal tibia. The changing pattern of bone geometry and microarchitecture of ADHR patients were similar to XLH patients but showed less deficit and stronger bone strength.
ADHR patients presented increased total area and cortical perimeter in distal radius, and obvious defect in cancellous bone in distal tibia. FGF23 have impairment effect on trabecular bone especially in weight bearing site.
常染色体显性低磷性佝偻病(ADHR)是一种由成纤维细胞生长因子23(FGF23)基因激活突变引起的罕见疾病。随着FGF23的激活,ADHR是探索FGF23对骨骼发育和矿化影响的良好模型。然而,ADHR患者的骨微结构研究较少。本研究旨在阐明ADHR患者的骨骼特性,并阐明FGF23对承重骨和非承重骨的影响。
通过高分辨率外周定量CT(HR-pQCT)分析11例ADHR受试者以及性别和年龄匹配的健康对照者的骨微结构。通过比较桡骨远端和胫骨远端的骨微结构,探讨FGF23突变对承重骨和非承重骨的影响。比较7例ADHR患者和7例年龄及性别匹配的XLH患者的骨密度、骨微结构和骨强度。
在11例FGF23突变的受试者中,10例患者有明显症状,其中5例接受了1 - 3年的铁补充剂、中性磷酸盐和骨化三醇治疗。有症状的患者X线显示骨密度低和骨折,骨密度(aBMD)的Z值降低(L1 - L4:-1.3±1.4,股骨颈:-2.1±1.8,全髋:-1.85±1.6)。与对照组相比,对5例未经治疗的ADHR患者进行HR-pQCT分析显示,桡骨远端的总面积增加(+61.6%,p = 0.03)和皮质周长增加(+17.2%,p = 0.03)。桡骨远端的其他参数未发现显著差异。在胫骨远端,患者的松质骨出现明显缺陷,骨小梁体积骨密度(trabecular vBMD)降低(-62.9%,p = 0.003)、骨小梁骨体积分数(trabecular BV/TV)降低(-48.7%,p = 0.003)和骨小梁数量减少(-42.2%,p = 0.001)。相应地,骨小梁间距增加(+113.3%,p = 0.007)和骨小梁网络不均匀性增加(+226.7%,p = 0.001)。除另外5例接受治疗的患者外,骨微结构变化呈现相似模式,但桡骨远端总面积和皮质周长的增加不再具有统计学意义。无症状的ADHR患者胫骨远端的总体积骨密度、骨小梁体积骨密度和骨小梁骨体积分数略有降低。ADHR患者的骨几何形状和微结构变化模式与XLH患者相似,但缺陷较少且骨强度较强。
ADHR患者桡骨远端的总面积和皮质周长增加,胫骨远端的松质骨有明显缺陷。FGF23对骨小梁骨有损害作用,尤其是在承重部位。